New drug delivery system developed to prevent immune activation.
Marshall
H
H
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology*; D016503:Drug Delivery Systems / Q000379:methods*; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000276:immunology; D008863:Microspheres; D010587:Phagocytosis; D011092:Polyethylene Glycols / Q000008:administration & dosage; D011108:Polymers / Q000008:administration & dosage
D000970:Antineoplastic Agents; D011108:Polymers; D011092:Polyethylene Glycols